Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution
Kerstin Thol, Piotr Pawlik, Nicholas McGranahan
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 459
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 121
Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis
May Soe Thu, Thunnicha Ondee, Tanawin Nopsopon, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 280-280
Open Access | Times Cited: 32
Nivolumab for Patients With High-Risk Oral Leukoplakia
Glenn J. Hanna, Alessandro Villa, Shuvro P. Nandi, et al.
JAMA Oncology (2023) Vol. 10, Iss. 1, pp. 32-32
Open Access | Times Cited: 30
Advances in nanomedicines for lymphatic imaging and therapy
Pan He, Haitian Tang, Yating Zheng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance
Dexin Xu, Wenhai Wang, Duo Wang, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 388-406
Open Access | Times Cited: 12
FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer
Haiyang Li, Na Zheng, Anning Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 9
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Radiation-targeted immunotherapy: A new perspective in cancer radiotherapy
Lihui Xuan, Chenjun Bai, Zhao Ju, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 1-11
Closed Access | Times Cited: 13
Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response
Shaoqing Chen, Duo Xie, Zan Li, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness
Karla Andrade de Oliveira, Surojeet Sengupta, Anil Yadav, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy - a review
Marek Zdrenka, Adam Kowalewski, Navid Ahmadi, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 10
Impacts of live and artificial feed on histology, biochemical indicators, gene expression, and bacterial resistance in mandarin fish (Siniperca chuatsi)
Shunli Che, Jiawei Chen, Zhang Hai, et al.
Fish & Shellfish Immunology (2025), pp. 110169-110169
Closed Access
Dendritic cells pulsed with penetratin-OLFM4 inhibit the growth and metastasis of melanoma in mice
Bum-Seo Baek, Hyunmi Park, Ji‐Woong Choi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117083-117083
Open Access | Times Cited: 3
The role of immune subtyping in glioma mRNA vaccine development
Alexandro Guterres, Mayla Abrahim, Patrícia Neves
Immunotherapy (2023) Vol. 15, Iss. 13, pp. 1057-1072
Closed Access | Times Cited: 6
Life history dynamics of evolving tumors: insights into task specialization, trade-offs, and tumor heterogeneity
Mahmoud Ahmed, Deok Ryong Kim
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review
Yunhao Wu, Jin Shang, Xinyue Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Immunotherapy with Checkpoint Inhibitors

(2024), pp. 253-299
Closed Access
Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response
Shaoqing Chen, Duo Xie, Jiguang Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A robust primary liver cancer subtype related to prognosis and drug response based on a multiple combined classifying strategy
Jielian Deng, Guichuan Lai, Cong Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25570-e25570
Open Access
Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
Zelin Weng, Zihang Mai, Jianye Yuan, et al.
Research Square (Research Square) (2024)
Open Access
Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden
Ivan P. Gorlov, Olga Y. Gorlova, Spyridon Tsavachidis, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
Zelin Weng, Zihang Mai, Jianye Yuan, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 11, pp. 2021-2035
Open Access
A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens
Ramiro Martinez, C. Finocchiaro, Louis Delhaye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response
Zheng Hu, Shaoqing Chen, Duo Xie, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top